月旦知識庫
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫學   財經   社會學   教育   其他 大陸期刊   核心   非核心 DOI文章
查看詳細全文
篇名
預測愛滋感染者決定服藥之服藥準備度的最佳臨床切點
並列篇名
Ideal Medication-Readiness Cutoff Score for Initiating Antiviral Therapy in HIV Patients
作者 謝佳吟賴怡因陳嬿今林佳諄劉麗芳柯乃熒
中文摘要
背景:2016年起愛滋感染者的服藥時機為診斷後立即服藥,選擇合適臨床評估工具,客觀地評估感染者服藥準備度對服藥的決定十分重要。目的:(1)比較開始服藥與未曾服藥的準備度差異,(2)比較開始服藥與未曾服藥二組其服藥準備度隨時間變化情形,(3)鑑別決定服藥之服藥準備度最佳臨床切點。方法:採多中心世代研究法,共297位2014年後新診斷愛滋感染尚未開始服藥者,共追蹤4個時程:基準值、用藥後一個月、3–6個月及9–12個月。資料收集包括人口學、服藥準備度中文量表(HIV Medication Readiness Scale, HMRS)及兩題簡易自評量尺(自覺服藥準備度、自覺信心程度)。結果:224位感染者(75.4%)決定開始服用抗病毒藥物。開始服藥者服藥準備度平均分數隨追蹤時程逐漸增加,且平均分數皆顯著高於未曾服藥者(p<.001)。簡易自評量尺之平均分數,開始服藥者皆顯著高於未曾服藥者(p<.001)。各工具最佳切點分別為:HMRS23.5分;自覺服藥準備度5.5分;自覺信心程度6.5分。結論:實務應用本研究顯示中文版HMRS23.5分可做為評估愛滋感染者服藥時機的最佳切點。愛滋照顧專業人員可以簡易自評量尺做為評估感染者的服藥準備度是否決定開始服藥的工具。
英文摘要
Background: There has been a global consensus since 2016 that antiretroviral therapy (ART) should be initiated following HIV diagnosis regardless of CD4-count test results. Identifying an instrument that is able to accurately assess the readiness of HIV-infected persons for treatment initiation is thus critical. Purpose: (1) To evaluate the comparative readiness of patients receiving ART and those who are not yet on ART; (2) to evaluate the respective readiness variation within these 2 groups over a one-year period; and (3) to identify the cutoff value for medication readiness that indicates the ideal time to initiate ART. Method: A multicenter cohort study design was conducted and 297 newly diagnosed patients with HIV were enrolled at four time points, including: baseline and at 1, 3-6, and 9-12 months after ART initiation. Data collection included a demographics datasheet, the Chinese version of the HIV Medication Readiness Scale (HMRS), and 2 items, readiness to take ART for a long period of time and confidence in adhering to ART, which were scored using a 10-point Likert scale. Results: Overall, 224 (75.4%) of the participants had initiated ART. Over time, the medication readiness of participants with ART initiation had increased significantly over that of non-ART user (p < .001). The mean scores of the 2-item self-rated readiness scale for patients with ART initiation were significantly greater than those without (p < .001). The cutoff values for HMRS, self-rating readiness for ART, and confidence in adherence to ART were 23.5, 5.5, and 6.5, respectively. Conclusions/Implications for Practice: The optimal cutoff value of the Chinese version HMRS for evaluating HAART initiation among persons with HIV infection was 23.5. HIV healthcare professionals may apply the Chinese version HMRS and the two simple self-rated items as a clinical tool for quickly assessing the initiation of ART in people living with HIV.
起訖頁 54-63
關鍵詞 愛滋病高效能抗愛滋病毒治療開始服藥愛滋病服藥準備度量表HIVhighly active antiretroviral therapy (HAART initiation)HIV Medication Readiness Scale (HMRS)
刊名 護理雜誌  
期數 201804 (65:2期)
出版單位 臺灣護理學會
該期刊-上一篇 全身性紅斑性狼瘡女性睡眠與晝夜血壓相關性及預測因子之初探
該期刊-下一篇 精神病患復元歷程之相關性研究
 

新書閱讀



最新講座


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄